Minchom, Anna <br/><br/>
Molecular and immunological features of a prolonged exceptional responder with malignant pleural mesothelioma treated initially and rechallenged with pembrolizumab.  [electronic resource] 

 -  Journal for immunotherapy of cancer  03 2020 
<br/><br/> Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2051-1426 
<br/><br/><label>Standard No.: </label>10.1136/jitc-2020-000713  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antibodies, Monoclonal, Humanized--therapeutic use<br/>B7-H1 Antigen--analysis<br/>Biomarkers, Tumor--analysis<br/>Female<br/>Humans<br/>Lung Neoplasms--drug therapy<br/>Mesothelioma--drug therapy<br/>Mesothelioma, Malignant<br/>Pleural Neoplasms--drug therapy<br/>Prognosis<br/>Retreatment--methods